Khan Najatinsider trades

In SEC Form 4 filings, Khan Najat is listed as CEO and President of Recursion Pharmaceuticals, Inc. (RXRX). In the last 90 days, Khan Najat sold $78.8K of Recursion Pharmaceuticals, Inc. (RXRX) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
RXRXRecursion Pharmaceuticals, Inc.	CEO and President	1	Sep 10

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-10

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
RXRXRecursion Pharmaceuticals, Inc.	Sep 8	Sep 10	S	22,408	$3.52	Sale −$78,822	2,072,890	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.